Allero Therapeutics develops next generation immunotherapies for allergic and autoimmune disease patients. Its proprietary SOMIT (Specific OroMucosal ImmunoTherapy) technology is designed to induce long-lasting antigen-specific tolerance.
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Curie Capi... | curiecapit... |
| - | Swanbridge... | swanbridge... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 22.12.2021 | Largest-ever funding round from EIC Accelerator: EC selects ... | The European Commission has announced the selection of 99 innovative startups and SMEs to be funded ... | siliconcan... |